Luminice— 510(k) K214100

Substantially Equivalent

Premier North America, Inc.

FDA 510(k) clearance K214100 for Luminice, Substantially Equivalent on 2022-02-24. Applicant: Premier North America, Inc..

Clearance details

Applicant
Premier North America, Inc.
Product code
Code NFO
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Fort Lauderdale, FL, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.